Skip to main content
logo
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
15.14
+0.04 (0.26%)
At close: Dec 12, 2025

ETR:1SXP Revenue

In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M EUR with 3.04% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 247.58M in the quarter ending September 30, 2025, with 4.44% growth.

Revenue
986.21M
Revenue Growth
+3.04%
P/S Ratio
2.31
Revenue / Employee
206.54K
Employees
4,690
Market Cap
2.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2025986.21M29.12M3.04%
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.87B
Siemens Healthineers AG23.38B
Fresenius SE & Co. KGaA22.45B
Merck KGaA21.27B
Fresenius Medical Care AG19.64B
Sartorius Aktiengesellschaft3.52B
Redcare Pharmacy NV2.82B
Fielmann Group AG2.42B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News